Danaher
Danaher is a global science and technology innovator that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company operates through a decentralized model of over 15 operating companies, unified by the Danaher Business System (DBS) to drive continuous improvement in biotechnology, life sciences, and diagnostics. Its value proposition centers on accelerating the power of science to improve human health through a high level of recurring revenue from consumables and services.
Financials
Based on Q1 2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricBusiness Segments
Diagnostics
primaryProvides clinical instruments and software used by healthcare facilities to diagnose disease and inform treatment decisions in laboratory and point-of-care settings.
CEPHEID, RADIOMETER, LEICA BIOSYSTEMS, MAMMOTOME, HEMOCUE, GeneXpert systems, Blood gas analyzers, Anatomical pathology instrumentation
Hospitals, Physicians' offices, Reference laboratories, Blood banks, Pathologists
Biotechnology
majorProvides equipment, consumables, and services used to advance the research, development, and manufacture of biological medicines, including monoclonal antibodies and gene therapies.
CYTIVA, PALL, Chromatography resins, Filtration technologies, Single-use hardware, Cell culture media
Pharmaceutical companies, Biopharmaceutical companies, Contract manufacturing organizations (CMO), Translational medicine institutions
Life Sciences
majorOffers instruments and consumables used to study DNA, RNA, and proteins to understand diseases and manufacture new drugs and vaccines.
ABCAM, ALDEVRON, BECKMAN COULTER, SCIEX, IDT, Mass spectrometers, Confocal microscopes, Automated liquid handling systems, Custom DNA/RNA oligonucleotides
Research institutions, Universities, Medical schools, Contract development and manufacturing organizations (CDMO), Industrial manufacturers
Segment Financials
Diagnostics — Identifiable assets
View metricLife Sciences — Identifiable assets
View metricBiotechnology — Identifiable assets
View metricBusiness Overview
Competitive Position
Danaher holds leadership positions across its three core segments, leveraging its proprietary Danaher Business System (DBS) to maintain high margins and operational efficiency.
Geographies
North America, Europe, Asia, High-growth markets
Customer Segments
Healthcare providers, Academic and research institutions, Pharmaceutical and biotech companies
Upstream Dependencies
Metallic-based components, Electronic components, Chemical raw materials, Plastics and petroleum-based products, OEM product suppliers
Downstream Customers
Hospitals and clinical laboratories, Biopharmaceutical manufacturers, Academic research universities, Governmental healthcare entities
Competitors & Partners
Competitors
Thermo Fisher Scientific
TMO
Broad competitor in life sciences and diagnostics
Agilent Technologies
A
Competitor in analytical instrumentation and life sciences
Waters Corporation
WAT
Competitor in life sciences and diagnostics
Becton, Dickinson and Company
BDX
Competitor in life sciences and diagnostics
Mettler-Toledo International, Inc.
MTD
Competitor in life sciences and environmental analytical tools
Corning
GLW
Competitor in Life Sciences
Dover
DOV
Competitor in life sciences and water quality segments similar to Dover's biopharma and process solutions
Xylem
XYL
Competitor in water quality and analytical instrumentation
Veralto
VLTO
Former parent company with overlapping industrial technology heritage
Entegris
ENTG
Competitor in Advanced Purity Solutions (part of Danaher)
Partners
U.S. Food and Drug Administration
Regulatory body governing medical device clearances and approvals
Subsidiaries
Cytiva
Bioprocessing and life sciences brand
Pall Corporation
Filtration, separation, and purification specialist
Beckman Coulter
Clinical diagnostics and life sciences automation
Cepheid
Molecular diagnostics systems
Abcam
Protein consumables and antibodies
Aldevron
Genomic medicine and plasmid DNA manufacturing
Leica Microsystems
Microscopy and visualization technology
Integrated DNA Technologies (IDT)
Custom nucleic acid products
Radiometer
Acute care diagnostics
Danaher FAQ
Common questions about Danaher
Danaher is a global science and technology innovator that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company operates through a decentralized model of over 15 operating companies, unified by the Danaher Business System (DBS) to drive continuous improvement in biotechnology, life sciences, and diagnostics. Its value proposition centers on accelerating the power of science to improve human health through a high level of recurring revenue from consumables and services.
Danaher (DHR) has a market capitalization of $122.68B and trades on NYSE.
Danaher generated $24.8B in trailing twelve-month revenue with net income of $3.7B, representing a net margin of 14.9%. Gross margin stands at 58.9%, with free cash flow of $5.3B. These figures are based on the Q1 2026 filing.
Danaher's key competitors include Thermo Fisher Scientific, Agilent Technologies, Waters Corp, and others. These companies compete in similar markets and product categories.
Danaher has approximately 63,000 employees.